Non-invasive quantification of glucose control, aging, and advanced maillard products by stimulated fluorescence

• US 5,601,079 A
• Filed: 09/16/1994
• Issued: 02/11/1997
• Est. Priority Date: 03/12/1992
• Status: Expired due to Fees

• Current Assignee: Bent Formby, Charles M. Peterson, Edwards Systems Technology, Inc., Jacob Y. Wong, GSBS Development Corp. (SPX Corporation)
• Original Assignee: Bent Formby, Charles M. Peterson, Jacob Y. Wong
• Inventors: Peterson, Charles M., Formby, Bent, Wong, Jacob Y.
• Primary Examiner(s): NOT, DEFINED
• Assistant Examiner(s): Winakur, Eric F.
• Application Number:
  US08/307,125
• Time in Patent Office: 879 Days
• Field of Search: 128/633, 128/665, 356/39, 356/40, 356/41
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/6826 Finger

Abstract

An apparatus for measuring the concentration of selected solute in a solution. This apparatus is particulary suitable for measuring the concentration of blood components, such as blood late Maillard products. A beam of exposing light is imaged through a wall of a containment vessel onto a region of the sample adjacent to this wall to induce from said selected solute emission of light that includes at least one emission peak that can be used to calculate the concentration of this solute. At least one detector is positioned to maximize the strength of detected signal, if other components of this solution strongly absorb the emitted light. The exposing light is directed such that the detected signal is maximized as a function of the path of this exposing light. A particular embodiment is a low-cost, non-invasive blood Maillard products concentration detector. In this embodiment, the containment vessel is preferably one of the patient'"'"'s fingers. At least two additional detected signals are monitored and processed at wavenumbers suitable for eliminating temperatures and pressure effects on the calculated blood glucose levels.

Claims

1. A non-invasive, blood chemistry measurement apparatus for measuring a concentration of a selected blood component within a sample of blood, said apparatus comprising:

a source of light in the wavelength range from 200-600 nm, whereby this light can pass through a person'"'"'s epidermis without undue absorption by the epidermis;

means for detecting light that is emitted from molecules of the selected blood component in response to light from said source of light; and

means, responsive to said means for detecting, for calculating a concentration of said selected blood component.

2. An apparatus as in claim 1 wherein said means for detecting comprises a detector that is responsive substantially only to light at a wavelength that is emitted substantially only by molecules of said selected blood component.

3. An apparatus as in claim 1 wherein said means for detecting produces N signals S₁, . . . , S_N, where N is greater than 1, and wherein said means for calculating a concentration is responsive to these N signals to calculate the concentration of said selected blood component.

4. An apparatus as in claim 3 wherein said means for detecting detects only light in a set of N wavelength bands and wherein each S_k, for k=1, . . . , N, is proportional to an intensity of light in the kth of these wavelength bands.

5. An apparatus as in claim 4 wherein said means for detecting comprises a set of N detectors, each of which detects light only in a uniquely associated one of these N wavelength bands.

6. An apparatus as in claim 3 wherein N=2, wherein S₁ is proportional to an intensity of light within a band substantially centered on an emission peak of blood late Maillard products substantially at 378 nm, wherein S₂ is proportional to an intensity of light within a band substantially centered on an emission peak of hemoglobin substantially at wavenumber 1,109 cm^-1, and wherein a calculated concentration of blood late Maillard products is corrected by use of S2 to take into account effects due to changes in blood volume intersected by the light from said light source.

7. An apparatus as in claim 3 wherein N=3, wherein S₁ is proportional to an intensity of light within a band substantially centered on an emission peak of blood late Maillard products substantially at wavenumber 1,040 cm^-1, wherein S₂ is proportional to an intensity of light within a band substantially centered on an emission peak of hemoglobin substantially at wavenumber 1,109 cm^-1, wherein S₃ is proportional to an intensity of light within a band that contains substantially only blackbody radiation from surrounding portions of this apparatus and wherein a calculated concentration of blood late Maillard products is corrected by use of S₂ and S₃ to take into account effects due to changes in temperature of a containment vessel and blood volume intersected by the light from said source.

8. An apparatus as in claim 1 wherein said source of light is selected from the class consisting of a laser diode, a photodiode, a super-radiant photodiode, and a flash lamp.

9. An apparatus as in claim 1 wherein the light from said source is imaged through a wall of a contaminant vessel onto a region of the sample adjacent to the wall and said means for detecting light comprises at least one optical detector positioned such that each ray of emitted light that is received by said at least one optical detector travels along a substantially minimum length path from its point of emission to said at least one detector, whereby absorption of emitted light by the solution is substantially minimized as a function of the position of said at least one detector.

10. An apparatus as in claim 9 wherein the light from said source is imaged onto a region within the containment vessel and the light travels from said source to this region along a path that is substantially perpendicular to a wall of said containment vessel at a point that this light passes through such wall, whereby the amount of absorption of this light by components of the solution other than said selected component is substantially minimized.

11. An apparatus as in claim 9 wherein the light has an intensity of at least 5 Watts/cm² within the region in which the light is imaged.

12. An apparatus as in claim 9 wherein said containment vessel is an animal'"'"'s body and the wall is the epidermis of such animal.

13. An apparatus as in claim 9 wherein said containment vessel is a finger of a human and the wall is the epidermis of this human.

14. An apparatus as in claim 9 further comprising:

temperature sensor means for measuring a temperature of a region from which light is received by said means for detecting; and

means for maintaining a substantially constant, selected temperature T of those regions of said apparatus that emit blackbody radiation to said means for detecting.

15. An apparatus as in claim 14 wherein T is equal to 37°

C.

16. An apparatus as in claim 1 further comprising:

a flat plate that is transparent to the emitted light, positioned such that light emitted from the sample of blood passes through this plate before reaching said means for detecting;

this plate providing a top surface against which a patient is to press a portion of the patient'"'"'s epidermis during a blood test with this apparatus.

17. An apparatus as in claim 16 further comprising:

an optical fiber that penetrates through this flat plate and carries light from said source of light to said sample of blood;

said means for detecting is adjacent to this fiber and this plate.

18. An apparatus as in claim 16 further comprising:

an optical fiber that does not penetrate through said flat plate and which transports light from said source of light and directs this light through a portion of said flat plate at a point at which a patient is to press a portion of this patient'"'"'s epidermis;

said means for detecting is adjacent to this fiber and this plate.